Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
NK Cell Therapy market report explains the definition, types, applications, major countries, and major players of the NK Cell Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
NantKwest Inc (USA)
Bristol-Myers Squibb (USA)
Chipscreen Biosciences (China)
Altor BioScience Corporation (USA)
NKT Therapeutics (USA)
Affimed NV (Netherlands)
Takeda Pharmaceutical (Japan)
Innate Pharma SA (France)
Sorrento Therapeutics Inc (USA)
By Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
By End-User:
Cancer
Cardiovascular Diseases
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global NK Cell Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 NK Cell Therapy Outlook to 2028- Original Forecasts
-
2.2 NK Cell Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term NK Cell Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global NK Cell Therapy Market- Recent Developments
-
6.1 NK Cell Therapy Market News and Developments
-
6.2 NK Cell Therapy Market Deals Landscape
7 NK Cell Therapy Raw Materials and Cost Structure Analysis
-
7.1 NK Cell Therapy Key Raw Materials
-
7.2 NK Cell Therapy Price Trend of Key Raw Materials
-
7.3 NK Cell Therapy Key Suppliers of Raw Materials
-
7.4 NK Cell Therapy Market Concentration Rate of Raw Materials
-
7.5 NK Cell Therapy Cost Structure Analysis
-
7.5.1 NK Cell Therapy Raw Materials Analysis
-
7.5.2 NK Cell Therapy Labor Cost Analysis
-
7.5.3 NK Cell Therapy Manufacturing Expenses Analysis
8 Global NK Cell Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global NK Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global NK Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global NK Cell Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global NK Cell Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global NK Cell Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise NK Cell Therapy Market Analysis and Outlook till 2022
-
10.1 Global NK Cell Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States NK Cell Therapy Consumption (2017-2022)
-
10.2.2 Canada NK Cell Therapy Consumption (2017-2022)
-
10.2.3 Mexico NK Cell Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany NK Cell Therapy Consumption (2017-2022)
-
10.3.2 UK NK Cell Therapy Consumption (2017-2022)
-
10.3.3 Spain NK Cell Therapy Consumption (2017-2022)
-
10.3.4 Belgium NK Cell Therapy Consumption (2017-2022)
-
10.3.5 France NK Cell Therapy Consumption (2017-2022)
-
10.3.6 Italy NK Cell Therapy Consumption (2017-2022)
-
10.3.7 Denmark NK Cell Therapy Consumption (2017-2022)
-
10.3.8 Finland NK Cell Therapy Consumption (2017-2022)
-
10.3.9 Norway NK Cell Therapy Consumption (2017-2022)
-
10.3.10 Sweden NK Cell Therapy Consumption (2017-2022)
-
10.3.11 Poland NK Cell Therapy Consumption (2017-2022)
-
10.3.12 Russia NK Cell Therapy Consumption (2017-2022)
-
10.3.13 Turkey NK Cell Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China NK Cell Therapy Consumption (2017-2022)
-
10.4.2 Japan NK Cell Therapy Consumption (2017-2022)
-
10.4.3 India NK Cell Therapy Consumption (2017-2022)
-
10.4.4 South Korea NK Cell Therapy Consumption (2017-2022)
-
10.4.5 Pakistan NK Cell Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh NK Cell Therapy Consumption (2017-2022)
-
10.4.7 Indonesia NK Cell Therapy Consumption (2017-2022)
-
10.4.8 Thailand NK Cell Therapy Consumption (2017-2022)
-
10.4.9 Singapore NK Cell Therapy Consumption (2017-2022)
-
10.4.10 Malaysia NK Cell Therapy Consumption (2017-2022)
-
10.4.11 Philippines NK Cell Therapy Consumption (2017-2022)
-
10.4.12 Vietnam NK Cell Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil NK Cell Therapy Consumption (2017-2022)
-
10.5.2 Colombia NK Cell Therapy Consumption (2017-2022)
-
10.5.3 Chile NK Cell Therapy Consumption (2017-2022)
-
10.5.4 Argentina NK Cell Therapy Consumption (2017-2022)
-
10.5.5 Venezuela NK Cell Therapy Consumption (2017-2022)
-
10.5.6 Peru NK Cell Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico NK Cell Therapy Consumption (2017-2022)
-
10.5.8 Ecuador NK Cell Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain NK Cell Therapy Consumption (2017-2022)
-
10.6.2 Kuwait NK Cell Therapy Consumption (2017-2022)
-
10.6.3 Oman NK Cell Therapy Consumption (2017-2022)
-
10.6.4 Qatar NK Cell Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia NK Cell Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates NK Cell Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria NK Cell Therapy Consumption (2017-2022)
-
10.7.2 South Africa NK Cell Therapy Consumption (2017-2022)
-
10.7.3 Egypt NK Cell Therapy Consumption (2017-2022)
-
10.7.4 Algeria NK Cell Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia NK Cell Therapy Consumption (2017-2022)
-
10.8.2 New Zealand NK Cell Therapy Consumption (2017-2022)
11 Global NK Cell Therapy Competitive Analysis
-
11.1 NantKwest Inc (USA)
-
11.1.1 NantKwest Inc (USA) Company Details
-
11.1.2 NantKwest Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 NantKwest Inc (USA) NK Cell Therapy Main Business and Markets Served
-
11.1.4 NantKwest Inc (USA) NK Cell Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bristol-Myers Squibb (USA)
-
11.2.1 Bristol-Myers Squibb (USA) Company Details
-
11.2.2 Bristol-Myers Squibb (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bristol-Myers Squibb (USA) NK Cell Therapy Main Business and Markets Served
-
11.2.4 Bristol-Myers Squibb (USA) NK Cell Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Chipscreen Biosciences (China)
-
11.3.1 Chipscreen Biosciences (China) Company Details
-
11.3.2 Chipscreen Biosciences (China) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Chipscreen Biosciences (China) NK Cell Therapy Main Business and Markets Served
-
11.3.4 Chipscreen Biosciences (China) NK Cell Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Altor BioScience Corporation (USA)
-
11.4.1 Altor BioScience Corporation (USA) Company Details
-
11.4.2 Altor BioScience Corporation (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Altor BioScience Corporation (USA) NK Cell Therapy Main Business and Markets Served
-
11.4.4 Altor BioScience Corporation (USA) NK Cell Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 NKT Therapeutics (USA)
-
11.5.1 NKT Therapeutics (USA) Company Details
-
11.5.2 NKT Therapeutics (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 NKT Therapeutics (USA) NK Cell Therapy Main Business and Markets Served
-
11.5.4 NKT Therapeutics (USA) NK Cell Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Affimed NV (Netherlands)
-
11.6.1 Affimed NV (Netherlands) Company Details
-
11.6.2 Affimed NV (Netherlands) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Affimed NV (Netherlands) NK Cell Therapy Main Business and Markets Served
-
11.6.4 Affimed NV (Netherlands) NK Cell Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Takeda Pharmaceutical (Japan)
-
11.7.1 Takeda Pharmaceutical (Japan) Company Details
-
11.7.2 Takeda Pharmaceutical (Japan) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Takeda Pharmaceutical (Japan) NK Cell Therapy Main Business and Markets Served
-
11.7.4 Takeda Pharmaceutical (Japan) NK Cell Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Innate Pharma SA (France)
-
11.8.1 Innate Pharma SA (France) Company Details
-
11.8.2 Innate Pharma SA (France) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Innate Pharma SA (France) NK Cell Therapy Main Business and Markets Served
-
11.8.4 Innate Pharma SA (France) NK Cell Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Sorrento Therapeutics Inc (USA)
-
11.9.1 Sorrento Therapeutics Inc (USA) Company Details
-
11.9.2 Sorrento Therapeutics Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Sorrento Therapeutics Inc (USA) NK Cell Therapy Main Business and Markets Served
-
11.9.4 Sorrento Therapeutics Inc (USA) NK Cell Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global NK Cell Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global NK Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global NK Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise NK Cell Therapy Market Analysis and Outlook to 2028
-
13.1 Global NK Cell Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States NK Cell Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada NK Cell Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.5 France NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia NK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.3 India NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines NK Cell Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico NK Cell Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador NK Cell Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain NK Cell Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait NK Cell Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman NK Cell Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar NK Cell Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia NK Cell Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates NK Cell Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria NK Cell Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa NK Cell Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt NK Cell Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria NK Cell Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia NK Cell Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand NK Cell Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of NK Cell Therapy
-
Figure of NK Cell Therapy Picture
-
Table Global NK Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global NK Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global NK Cell Therapy Consumption by Country (2017-2022)
-
Table North America NK Cell Therapy Consumption by Country (2017-2022)
-
Figure United States NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe NK Cell Therapy Consumption by Country (2017-2022)
-
Figure Germany NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure France NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC NK Cell Therapy Consumption by Country (2017-2022)
-
Figure China NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure India NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table South America NK Cell Therapy Consumption by Country (2017-2022)
-
Figure Brazil NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC NK Cell Therapy Consumption by Country (2017-2022)
-
Figure Bahrain NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa NK Cell Therapy Consumption by Country (2017-2022)
-
Figure Nigeria NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania NK Cell Therapy Consumption by Country (2017-2022)
-
Figure Australia NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table NantKwest Inc (USA) Company Details
-
Table NantKwest Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table NantKwest Inc (USA) NK Cell Therapy Main Business and Markets Served
-
Table NantKwest Inc (USA) NK Cell Therapy Product Portfolio
-
Table Bristol-Myers Squibb (USA) Company Details
-
Table Bristol-Myers Squibb (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb (USA) NK Cell Therapy Main Business and Markets Served
-
Table Bristol-Myers Squibb (USA) NK Cell Therapy Product Portfolio
-
Table Chipscreen Biosciences (China) Company Details
-
Table Chipscreen Biosciences (China) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chipscreen Biosciences (China) NK Cell Therapy Main Business and Markets Served
-
Table Chipscreen Biosciences (China) NK Cell Therapy Product Portfolio
-
Table Altor BioScience Corporation (USA) Company Details
-
Table Altor BioScience Corporation (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Altor BioScience Corporation (USA) NK Cell Therapy Main Business and Markets Served
-
Table Altor BioScience Corporation (USA) NK Cell Therapy Product Portfolio
-
Table NKT Therapeutics (USA) Company Details
-
Table NKT Therapeutics (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table NKT Therapeutics (USA) NK Cell Therapy Main Business and Markets Served
-
Table NKT Therapeutics (USA) NK Cell Therapy Product Portfolio
-
Table Affimed NV (Netherlands) Company Details
-
Table Affimed NV (Netherlands) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affimed NV (Netherlands) NK Cell Therapy Main Business and Markets Served
-
Table Affimed NV (Netherlands) NK Cell Therapy Product Portfolio
-
Table Takeda Pharmaceutical (Japan) Company Details
-
Table Takeda Pharmaceutical (Japan) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical (Japan) NK Cell Therapy Main Business and Markets Served
-
Table Takeda Pharmaceutical (Japan) NK Cell Therapy Product Portfolio
-
Table Innate Pharma SA (France) Company Details
-
Table Innate Pharma SA (France) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innate Pharma SA (France) NK Cell Therapy Main Business and Markets Served
-
Table Innate Pharma SA (France) NK Cell Therapy Product Portfolio
-
Table Sorrento Therapeutics Inc (USA) Company Details
-
Table Sorrento Therapeutics Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Inc (USA) NK Cell Therapy Main Business and Markets Served
-
Table Sorrento Therapeutics Inc (USA) NK Cell Therapy Product Portfolio
-
Figure Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Table North America NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure China NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
